Dae Ryong Cha (Dae R Cha)

Publication Activity (10 Years)

Years Active: 2014-2023
Publications (10 Years): 19

Top Topics

Chronic Kidney Disease

Epidermal Growth Factor Receptor

Top Venues

Life (Basel, Switzerland)

Animal cells and systems

Diabetes, obesity & metabolism

Journal of Korean medical science

This page only lists publications with an associated author ORCID identifier.

Publications

Soonil Koun, Hye-Jin Park, Su-Min Jung, Jin Joo Cha, Dae Ryong Cha, Young Sun Kang
Puromycin-induced kidney injury and subsequent regeneration in adult zebrafish. Animal cells and systems 27 (1) (2023)
Soonil Koun, Hye-Jin Park, Su-Min Jung, Jin Joo Cha, Dae Ryong Cha, Young Sun Kang
Puromycin-induced kidney injury and subsequent regeneration in adult zebrafish. Animal cells and systems 27 (1) (2023)
Sang Youb Han, Seung Hyun Han, Jung Yeon Ghee, Jin Joo Cha, Young Sun Kang, Dae Ryong Cha
SH3YL1 Protein Predicts Renal Outcomes in Patients with Type 2 Diabetes. Life (Basel, Switzerland) 13 (4) (2023)
Sang Youb Han, Jung Yeon Ghee, Jin Joo Cha, Young Sun Kang, Han Seong Kim, Dae Young Hur, Dae Ryong Cha
The Role of V-Set Ig Domain-Containing 4 in Chronic Kidney Disease Models. Life (Basel, Switzerland) 13 (2) (2023)
Sang Youb Han, Jung Yeon Ghee, Jin Joo Cha, Young Sun Kang, Han Seong Kim, Dae Young Hur, Dae Ryong Cha
The Role of V-Set Ig Domain-Containing 4 in Chronic Kidney Disease Models. Life (Basel, Switzerland) 13 (2) (2023)
Sang Youb Han, Seung Hyun Han, Jung Yeon Ghee, Jin Joo Cha, Young Sun Kang, Dae Ryong Cha
SH3YL1 Protein Predicts Renal Outcomes in Patients with Type 2 Diabetes. Life (Basel, Switzerland) 13 (4) (2023)
Sang Youb Han, Jung Yeon Ghee, Jin Joo Cha, Young Sun Kang, Han Seong Kim, Dae Young Hur, Dae Ryong Cha
The Role of V-Set Ig Domain-Containing 4 in Chronic Kidney Disease Models. Life (Basel, Switzerland) 13 (2) (2023)
Sang Youb Han, Jung Yeon Ghee, Jin Joo Cha, Young Sun Kang, Han Seong Kim, Dae Young Hur, Dae Ryong Cha
The Role of V-Set Ig Domain-Containing 4 in Chronic Kidney Disease Models. Life (Basel, Switzerland) 13 (2) (2023)
Sang Youb Han, Seung Hyun Han, Jung Yeon Ghee, Jin Joo Cha, Young Sun Kang, Dae Ryong Cha
SH3YL1 Protein Predicts Renal Outcomes in Patients with Type 2 Diabetes. Life (Basel, Switzerland) 13 (4) (2023)
Soonil Koun, Hye-Jin Park, Su-Min Jung, Jin Joo Cha, Dae Ryong Cha, Young Sun Kang
Puromycin-induced kidney injury and subsequent regeneration in adult zebrafish. Animal cells and systems 27 (1) (2023)
Soonil Koun, Hye-Jin Park, Su-Min Jung, Jin Joo Cha, Dae Ryong Cha, Young Sun Kang
Puromycin-induced kidney injury and subsequent regeneration in adult zebrafish. Animal cells and systems 27 (1) (2023)
Sang Youb Han, Seung Hyun Han, Jung Yeon Ghee, Jin Joo Cha, Young Sun Kang, Dae Ryong Cha
SH3YL1 Protein Predicts Renal Outcomes in Patients with Type 2 Diabetes. Life (Basel, Switzerland) 13 (4) (2023)
Sang Youb Han, Jung Yeon Ghee, Jin Joo Cha, Young Sun Kang, Dae Young Hur, Han Seong Kim, Dae Ryong Cha
Upregulation of VSIG4 in Type 2 Diabetic Kidney Disease. Life (Basel, Switzerland) 12 (7) (2022)
Sang Youb Han, Hye Kyoung Song, Jin Joo Cha, Jee Young Han, Young Sun Kang, Dae Ryong Cha
Farnesoid X receptor (FXR) agonist ameliorates systemic insulin resistance, dysregulation of lipid metabolism, and alterations of various organs in a type 2 diabetic kidney animal model. Acta diabetologica 58 (4) (2021)
Hye Sook Min, Ji Eun Lee, Jung Yeon Ghee, Young Sun Kang, Jin Joo Cha, Jee Young Han, Sang Youb Han, Dae Ryong Cha
A Novel Dipeptidyl Peptidase-4 Inhibitor DA-1229 Ameliorates Tubulointerstitial Fibrosis in Cyclosporine Nephrotoxicity in Mice. Life (Basel, Switzerland) 11 (3) (2021)
Debra Dorotea, Ahreum Cho, Gayoung Lee, Guideock Kwon, Junghwa Lee, Pramod K Sahu, Lak Shin Jeong, Dae Ryong Cha, Hunjoo Ha
Orally active, species-independent novel A3 adenosine receptor antagonist protects against kidney injury in db/db mice. Experimental & molecular medicine 50 (4) (2018)
Sun A Yoon, Byoung G Han, Sung G Kim, Sang Y Han, Young I Jo, Kyung H Jeong, Kook H Oh, Hyeong C Park, Sun H Park, Shin W Kang, Ki R Na, Sun W Kang, Nam H Kim, Young H Jang, Seong H Shin, Dae Ryong Cha
Efficacy, safety and albuminuria-reducing effect of gemigliptin in Korean type 2 diabetes patients with moderate to severe renal impairment: A 12-week, double-blind randomized study (the GUARD Study). Diabetes, obesity & metabolism 19 (4) (2017)
Hye Sook Min, Jin Joo Cha, Kitae Kim, Jung Eun Kim, Jung Yeon Ghee, Hyunwook Kim, Ji Eun Lee, Jee-Young Han, Lak Shin Jeong, Dae Ryong Cha, Young Sun Kang
Renoprotective Effects of a Highly Selective A3 Adenosine Receptor Antagonist in a Mouse Model of Adriamycin-induced Nephropathy. Journal of Korean medical science 31 (9) (2017)
Sang Youb Han, Sun Ae Yoon, Byoung Geun Han, Sung Gyun Kim, Young-Il Jo, Kyung Hwan Jeong, Kook-Hwan Oh, Hyeong Cheon Park, Sun-Hee Park, Shin-Wook Kang, Ki-Ryang Na, Sun Woo Kang, Nam-Ho Kim, Younghwan Jang, Bogyeong Kim, Seonghye Shin, Dae Ryong Cha
Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40-week extension of the GUARD randomized study. Diabetes, obesity & metabolism 20 (2) (2017)
Hye Sook Min, Jung Eun Kim, Mi Hwa Lee, Hye Kyoung Song, Young Sun Kang, Mi Jin Lee, Ji Eun Lee, Hyun Wook Kim, Jin Joo Cha, Young Yoon Chung, Young Youl Hyun, Jee Young Han, Dae Ryong Cha
Dipeptidyl peptidase IV inhibitor protects against renal interstitial fibrosis in a mouse model of ureteral obstruction. Laboratory investigation; a journal of technical methods and pathology 94 (6) (2014)